8 (1 to 3 p.m.): Final committee meeting to lock in the official list of budget recommendations
The White House says that "for too many Americans, these critical treatments are too expensive and therefore out of reach," and, "without insurance coverage, these drugs can cost someone as much as $1,000 a month." GLP-1 (glucagon-like peptide) receptor agonists are commonly prescribed to patients with type 2 diabetes (to stabilize blood glucose levels) or obesity (to assist with weight loss)
At the same dose (for 7 days) it improved functional enzymes and histopathology of the liver in cyclophosphamide-induced liver injury in Wistar rats
Clinical evidence supports it: The SEMALEAN study (2025) found a 15% reduction in visceral fat and an average of 12 kg total weight loss over six months
We explain how they differ
The ARC AgRP-PVN TRH/CART Circuit In contrast to the regulatory mysteries underlying the development of obesity, neural mechanisms that mediate the resistance to loss of BW and energy stores are relatively well characterized